Koers SanBio Company Limited OTC Markets
Aandelen
SNBO.Y
US7995731004
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,81 USD | -48,72% | -.--% | -.--% |
19/03 | SANBIO COMPANY LIMITED : Jefferies & Co. behoudt het verkoopadvies | ZM |
19/03 | Transcript : SanBio Company Limited, 2024 Earnings Call, Mar 19, 2024 |
Omzet 2025 * | - | Omzet 2026 * | 660 mln. 4,26 mln. 3,96 mln. | Marktkapitalisatie | 29,37 mld. 190 mln. 176 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2025 * | -3,3 mld. -21,27 mln. -19,79 mln. | Nettowinst (verlies) 2026 * | -3,53 mld. -22,77 mln. -21,19 mln. | EV/omzet 2025 * | - |
Nettoschuld 2025 * | 226 mln. 1,46 mln. 1,36 mln. | Nettoschuld 2026 * | 3,03 mld. 19,58 mln. 18,22 mln. | EV/omzet 2026 * | 49,1 x |
K/w-verhouding 2025 * |
-8,72
x | K/w-verhouding 2026 * |
-8,17
x | Werknemers | 29 |
Dividendrendement 2025 * |
-
| Dividendrendement 2026 * |
-
| Vrij verhandelbaar | 71,15% |
Recentste transcriptie over SanBio Company Limited
1 dag | -48,72% | ||
1 maand | -48,72% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Keita Mori
CEO | Chief Executive Officer | 56 | 27-02-13 |
Shinya Hirata
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Noboru Kotani
BRD | Director/Board Member | 67 | 01-03-13 |
Keita Mori
CEO | Chief Executive Officer | 56 | 27-02-13 |
Toru Kawanishi
CHM | Chairman | 56 | 27-02-13 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,44% | 106 mld. | |
+0,82% | 104 mld. | |
+6,72% | 23,25 mld. | |
-13,89% | 22,5 mld. | |
-6,64% | 18,7 mld. | |
-37,26% | 17,95 mld. | |
-10,98% | 16,99 mld. | |
+8,67% | 14,26 mld. | |
+41,08% | 12,76 mld. |
- Beurs
- Aandelen
- Koers 4592
- Koers SNBO.Y